Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25047743)

  • 1. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
    Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
    Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
    J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
    Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
    J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
    Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
    Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
    J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
    Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
    Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glutathione-S-transferase expression in oral squamous cell carcinoma].
    Pannone G; Lo Muzio L; Pappalardo S; Bambini F; Rubini C; Fioroni M; Fanali S
    Minerva Stomatol; 2000 Mar; 49(3):107-17. PubMed ID: 20047209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes.
    Tremblay S; Pintor Dos Reis P; Bradley G; Galloni NN; Perez-Ordonez B; Freeman J; Brown D; Gilbert R; Gullane P; Irish J; Kamel-Reid S
    Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):958-66. PubMed ID: 16982972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade.
    Zhu DW; Yang X; Yang CZ; Ma J; Liu Y; Yan M; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
    Oral Oncol; 2013 Jun; 49(6):542-50. PubMed ID: 23403091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
    Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
    Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wu CC; Fang KH; Tsai CY; Chang YL; Liu SC; Kao HK
    Oral Oncol; 2013 Aug; 49(8):802-7. PubMed ID: 23769451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Estrogen Receptors in OSCC in Relation to Histopathological Grade.
    Doll C; Arsenic R; Lage H; Jöhrens K; Hartwig S; Nelson K; Raguse JD
    Anticancer Res; 2015 Nov; 35(11):5867-72. PubMed ID: 26504009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T; Liu G; Wang L; Liu H
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
    Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
    Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
    Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
    Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
    Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
    Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.